Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Bone Neoplasms 1

Interventions

Zoledronic Acid 2Vincristine 2Temozolomide 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2selinexor 1saracatinib 1samarium Sm-153 lexidronam 1robatumumab 1pembrolizumab 1pegfilgrastim 1angiotensin I (1-7) 1Transcranial Direct Current Stimulation 1Tranexamic Acid 1Sunitinib 1Standard of Care 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Samarium 1Radiation 1Proton Therapy 1Pregabalin 1Practice Guidelines as Topic 1Plicamycin 1Palliative Care 1Nivolumab 1Neutrons 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bone Neoplasms × Neutrons × Clear all
NCT03002454 2017-10-03

Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo

University of Manitoba

Phase 3 Terminated
4 enrolled 5 charts
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡